FI810934L - PHARMACEUTICAL PRODUCT - Google Patents

PHARMACEUTICAL PRODUCT

Info

Publication number
FI810934L
FI810934L FI810934A FI810934A FI810934L FI 810934 L FI810934 L FI 810934L FI 810934 A FI810934 A FI 810934A FI 810934 A FI810934 A FI 810934A FI 810934 L FI810934 L FI 810934L
Authority
FI
Finland
Prior art keywords
pharmaceutical product
pharmaceutical
product
Prior art date
Application number
FI810934A
Other languages
Finnish (fi)
Other versions
FI70670C (en
FI70670B (en
Inventor
Murray Arthur Kaplan
Alphonse Peter Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI810934L publication Critical patent/FI810934L/en
Application granted granted Critical
Publication of FI70670B publication Critical patent/FI70670B/en
Publication of FI70670C publication Critical patent/FI70670C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI810934A 1980-03-31 1981-03-26 FOERFARANDE FOER FRAMSTAELLNING AV EN STABIL CONCENTRATION CISPLATIN-LOESNING I ETT LOESNINGSMEDEL FI70670C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31
US13537380 1980-03-31

Publications (3)

Publication Number Publication Date
FI810934L true FI810934L (en) 1981-10-01
FI70670B FI70670B (en) 1986-06-26
FI70670C FI70670C (en) 1986-10-06

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810934A FI70670C (en) 1980-03-31 1981-03-26 FOERFARANDE FOER FRAMSTAELLNING AV EN STABIL CONCENTRATION CISPLATIN-LOESNING I ETT LOESNINGSMEDEL

Country Status (30)

Country Link
JP (1) JPS56152415A (en)
KR (1) KR860000841B1 (en)
AR (1) AR225500A1 (en)
AT (1) AT370996B (en)
AU (1) AU541056B2 (en)
BE (1) BE888209A (en)
CA (1) CA1162479A (en)
CH (1) CH647481A5 (en)
CS (1) CS246051B2 (en)
DD (1) DD157762A5 (en)
DE (1) DE3112272A1 (en)
DK (1) DK158564C (en)
ES (1) ES8206545A1 (en)
FI (1) FI70670C (en)
FR (1) FR2480605A1 (en)
GB (1) GB2074028B (en)
GR (1) GR72769B (en)
HU (1) HU183379B (en)
IE (1) IE51070B1 (en)
IL (1) IL62517A (en)
IT (1) IT1170838B (en)
LU (1) LU83270A1 (en)
NL (1) NL8101531A (en)
NO (1) NO156675C (en)
NZ (1) NZ196519A (en)
PH (1) PH17152A (en)
PT (1) PT72774B (en)
SE (1) SE455045B (en)
SU (1) SU1056893A3 (en)
ZA (1) ZA812084B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (en) * 1982-09-23 1987-01-21 Erba Farmitalia PHARMACOLOGICAL COMPOSITIONS BASED ON CISPLATIN AND METHOD FOR THEIR OBTAINMENT
NL8303657A (en) * 1983-10-24 1985-05-17 Pharmachemie Bv SOLUTION, STABLE, AQUEOUS, AQUEOUS, CONTAINING SOLUTION OF CISPLATINE, AND METHOD OF PREPARING THEREOF.
FI895340A0 (en) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co HYPERTONISK CISPLATIN-LOESNING.
PT929293E (en) * 1996-08-23 2004-03-31 Sequus Pharm Inc LIPOSOMES CONTAINING A COMPOSITE OF CISPLATIN
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (en) 2004-03-26 2010-04-07 オンキヨー株式会社 Switching amplifier
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
ES2928931T3 (en) 2018-03-29 2022-11-23 Project Pharmaceutics Gmbh liquid pharmaceutical formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (en) * 1978-05-30 1986-06-09 Bristol Myers Co STABLE, STERILE WATER DISPOSAL OF CISPLATIN IN UNIT DOSAGE FORM

Also Published As

Publication number Publication date
DK144281A (en) 1981-10-01
JPS56152415A (en) 1981-11-26
GB2074028B (en) 1983-09-21
DK158564B (en) 1990-06-11
NO811081L (en) 1981-10-01
ATA150481A (en) 1982-10-15
ZA812084B (en) 1982-04-28
IL62517A (en) 1984-01-31
NO156675B (en) 1987-07-27
NO156675C (en) 1987-11-04
DE3112272C2 (en) 1990-09-27
SE455045B (en) 1988-06-20
GR72769B (en) 1983-12-02
JPS6360008B2 (en) 1988-11-22
FI70670C (en) 1986-10-06
AT370996B (en) 1983-05-25
IE51070B1 (en) 1986-09-17
FR2480605A1 (en) 1981-10-23
AR225500A1 (en) 1982-03-31
ES500869A0 (en) 1982-08-16
AU541056B2 (en) 1984-12-13
LU83270A1 (en) 1981-10-29
AU6816681A (en) 1981-10-08
CH647481A5 (en) 1985-01-31
IT1170838B (en) 1987-06-03
GB2074028A (en) 1981-10-28
DE3112272A1 (en) 1982-04-29
PH17152A (en) 1984-06-13
NZ196519A (en) 1983-06-17
KR830004849A (en) 1983-07-20
PT72774B (en) 1982-11-16
NL8101531A (en) 1981-10-16
DD157762A5 (en) 1982-12-08
SE8101990L (en) 1981-11-13
IT8148090A0 (en) 1981-03-24
KR860000841B1 (en) 1986-07-09
CA1162479A (en) 1984-02-21
BE888209A (en) 1981-09-30
IL62517A0 (en) 1981-05-20
IE810715L (en) 1981-09-30
ES8206545A1 (en) 1982-08-16
FI70670B (en) 1986-06-26
FR2480605B1 (en) 1984-05-11
PT72774A (en) 1981-04-01
SU1056893A3 (en) 1983-11-23
DK158564C (en) 1990-11-05
HU183379B (en) 1984-04-28
CS246051B2 (en) 1986-10-16

Similar Documents

Publication Publication Date Title
FI821123L (en) LOCAL ANVAENDBARA PHARMACEUTICAL PRODUCT
DK198582A (en) FORMED CEMENTIC PRODUCTS
PT73686A (en) PHARMACEUTICAL FORMULATION
FI814013L (en) FOERPACKNING FOER BRAECKLIGA PRODUKTER
BE887099A (en) PHARMACEUTICAL PREPARATION AGAINST ACNE
DK345682A (en) PHARMACEUTICAL EXPIENSES
FI810558L (en) 2 (1H) -PYRIDINONDERIVES DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT
FI810056L (en) PHARMACEUTICAL FORM
DK208784D0 (en) PHARMACEUTICAL PRODUCT
DE3279436D1 (en) CORPUSCULES CONTAINING MEDICAMENTS
FI850455L (en) PHARMACEUTICAL PRODUCT.
FI862590A (en) PHARMACEUTICAL PRODUCT.
BR8101177A (en) MEDICATION SET
FI813412L (en) 3-AMINOPROPOXIPHENYL DERIVATIVES DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT
DK116382A (en) TOBACCO PRODUCT
FI810934L (en) PHARMACEUTICAL PRODUCT
FI803846L (en) PHARMACEUTICAL PRODUCT
FI831687L (en) PHARMACEUTICAL BLANDNINGAR VILKA INNEHAOLLER FLERE AKTIVA BESTAONDSDELAR
FI830399L (en) MJOELDRYGE ALKALOIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT
ES502737A0 (en) IMPROVEMENTS IN THE MANUFACTURE OF MEDICINAL CAPSULES
FI822980L (en) FURANOKROMONDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT
FI811880L (en) PHARMACEUTICAL BICYCLISKA FOERENINGAR OCH KOMPOSITIONER
FI801334A (en) SAETT FOER VAERMEBEHANDLING AV KERAMISKA PRODUKTER
FI813953L (en) BIS-HYDROXIBENZYLDERIVAT DERAS FRAMSTAELLNINGSFOERFARANDEN OCHDESSA INNEHAOLLANDE PHARMACEUTICAL PRODUCT
IT1172075B (en) COSMETIC PRODUCT

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS CO